InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Schmid John P., Directeur. Director active across 3 companies, notably Xeris Pharmaceuticals INC. In total, 6 reports have been recorded. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
019,650 shares0
Common Stock
SEC:0001209191-22-037667:0·
015,000 shares0
Common Stock
SEC:0001867096-22-000091:0·
5,659 shares
Common Stock
SEC:0000899243-21-039257·
5,659 shares
Common Stock
SEC:0000899243-21-039323·
5,659 shares
Common Stock
SEC:0000899243-21-039257:0·
5,659 shares
Common Stock
SEC:0000899243-21-039323:0·
6 of 6 declarations
About Schmid John P.
John P. Schmid is a Director at Xeris Pharmaceuticals Inc, Xeris Biopharma Holdings, Inc., and Poseida Therapeutics, Inc. He participates in strategic decisions and oversees the activities of these companies. His experience in the pharmaceutical sector is valuable to the board.
